Non-marketable Equity Securities - Schedule of Non-Marketable Equity Securities (Details) - USD ($) $ in Millions |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Investments, Debt and Equity Securities [Abstract] | ||
| Initial cost | $ 6,389 | $ 6,388 |
| Cumulative upward adjustments | 293 | 293 |
| Cumulative impairment/downward adjustments | (599) | (497) |
| Carrying value | 6,083 | 6,184 |
| Non-marketable equity securities under equity method | 58 | 17 |
| Total | $ 6,141 | $ 6,201 |
| X | ||||||||||
- Definition Equity Securities without Readily Determinable Fair Value, Impairment and Downward Price Adjustment, Cumulative Amount No definition available.
|
| X | ||||||||||
- Definition Equity Securities without Readily Determinable Fair Value, Initial Cost No definition available.
|
| X | ||||||||||
- Definition Nonmarketable Equity Securities, Carrying Value No definition available.
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|